|
ZNF267 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.699700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.650010E-02 |
| Normal-vs-Stage2 |
1.402170E-04 |
| Normal-vs-Stage3 |
2.057500E-03 |
| Normal-vs-Stage4 |
9.210900E-04 |
| Stage1-vs-Stage2 |
8.700200E-03 |
| Stage1-vs-Stage3 |
9.377900E-02 |
| Stage1-vs-Stage4 |
3.295700E-02 |
| Stage2-vs-Stage3 |
9.605700E-02 |
| Stage2-vs-Stage4 |
2.664600E-01 |
| Stage3-vs-Stage4 |
5.900000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.161400E-03 |
| Normal-vs-AfricanAmerican |
1.407880E-02 |
| Normal-vs-Asian |
1.179790E-01 |
| Caucasian-vs-AfricanAmerican |
5.891800E-01 |
| Caucasian-vs-Asian |
5.777600E-01 |
| AfricanAmerican-vs-Asian |
4.085200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.836300E-03 |
| Normal-vs-Female |
4.544000E-03 |
| Male-vs-Female |
6.986400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.450000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.379360E-03 |
| Normal-vs-Age(61-80Yrs) |
8.2161000000025E-05 |
| Normal-vs-Age(81-100Yrs) |
5.902000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.257500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.24689999999539E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.251200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.525900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.227390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.434630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.854000E-01 |
| Classical-VS-Follicular |
9.99200722162641E-16 |
| Classical-VS-Other |
4.157000E-01 |
| Classical-VS-Normal |
4.804000E-02 |
| Tall-VS-Follicular |
2.05350000004323E-06 |
| Tall-VS-Other |
4.946600E-01 |
| Tall-VS-Normal |
3.146300E-02 |
| Follicular-VS-Other |
5.772200E-02 |
| Follicular-VS-Normal |
2.66679999971764E-07 |
| Other-VS-Normal |
4.337800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.164040E-04 |
| Normal-vs-N1 |
3.944600E-03 |
| N0-vs-N1 |
1.033630E-01 |
|
|
